LRMR
#3356
Larimar Therapeutics, Inc. - Common Stock
2.5 3 USD
-0.05%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-5.24%
Monatliche Änderung
-34.11%
6 month change
-48.47%
Jahresänderung
-39.33%
Vorheriger Schlusskurs
2.6 7
Open
2.6 6
Tief
2.5 3
Hoch
2.6 9
Financials
2017
Quarterly report, Q2 FY2017
Larimar Therapeutics, Inc. quarterly report, Q2 FY2017
10-Q
Current report, 21 Jun 2017
Larimar Therapeutics, Inc. current report, 21 June 2017
8-K
Current report, 09 May 2017
Larimar Therapeutics, Inc. current report, 09 May 2017
8-K
Current report, 04 May 2017
Larimar Therapeutics, Inc. current report, 04 May 2017
8-K
Quarterly report, Q1 FY2017
Larimar Therapeutics, Inc. quarterly report, Q1 FY2017
10-Q
Current report, 09 Mar 2017
Larimar Therapeutics, Inc. current report, 09 March 2017
8-K
2016
Annual report, FY2016
Larimar Therapeutics, Inc. annual report, FY2016
10-K
Current report, 09 Nov 2016
Larimar Therapeutics, Inc. current report, 09 November 2016
8-K
Quarterly report, Q3 FY2016
Larimar Therapeutics, Inc. quarterly report, Q3 FY2016
10-Q
Current report, 04 Aug 2016
Larimar Therapeutics, Inc. current report, 04 August 2016
8-K